Cargando…
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ejemplares similares
-
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
por: Nogami, Akihiko, et al.
Publicado: (2021) -
JCS/JHRS 2021 guideline focused update on non‐pharmacotherapy of cardiac arrhythmias
por: Nogami, Akihiko, et al.
Publicado: (2022) -
Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2016) -
Predictive ability of visit-to-visit blood pressure indices for adverse events in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry
por: Kodani, Eitaro, et al.
Publicado: (2023) -
Prognostic significance of nonsustained ventricular tachycardia in patients receiving cardiac resynchronization therapy for primary prevention: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2018)